IL6 and neoplasm: Further studies in mammary tumors revealed that IL6 produced by cancer cells interacts with IL6 receptor on aldehyde dehydrogenase 1-positive mesenchymal cells, whereby this IL6 signaling-mediated chemotaxis may facilitate recruitment of further MSC to the tumor microenvironment and induction of CXCL7 production by these cells.